Q1 2024 Revenue and Business Update
![]() |
MELBOURNE, Australia, April 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 31 March 2024 (Q1 2024).
Summary: Q1 2024 financial performance
The Company reports unaudited total revenue of US$114.9M[1] (AU$175.0M) an...





